SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CERo Therapeutics, Inc., a biopharmaceutical company pioneering the development of novel autologous engineered immune cell therapies, today announced new ...
SOUTH SAN FRANSCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (CERO), (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback